BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 38561743)

  • 1. CIP/KIP and INK4 families as hostages of oncogenic signaling.
    Csergeová L; Krbušek D; Janoštiak R
    Cell Div; 2024 Apr; 19(1):11. PubMed ID: 38561743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cip/Kip cyclin-dependent kinase inhibitors: brakes of the cell cycle engine during development.
    Nakayama K; Nakayama K
    Bioessays; 1998 Dec; 20(12):1020-9. PubMed ID: 10048302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody probes for p21WAF1/CIP1 and the INK4 family of cyclin-dependent kinase inhibitors.
    Thullberg M; Welcker M; Bartkova J; Kjerulff AA; Lukas J; Högberg J; Bartek J
    Hybridoma; 2000 Feb; 19(1):63-72. PubMed ID: 10768842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of Cip/Kip and Ink4 cyclin dependent kinase inhibitors by interferon-alpha in hematopoietic cell lines.
    Sangfelt O; Erickson S; Einhorn S; Grandér D
    Oncogene; 1997 Jan; 14(4):415-23. PubMed ID: 9053838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cip/Kip cell-cycle inhibitors: a neuro-oncological perspective.
    Mainprize TG; Taylor MD; Rutka JT; Dirks PB
    J Neurooncol; 2001 Feb; 51(3):205-18. PubMed ID: 11407593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation of INK4 and CIP/KIP families of cyclin-dependent kinase inhibitor in chronic lymphocytic leukaemia in Chinese patients.
    Chim CS; Fung TK; Wong KF; Lau JS; Law M; Liang R
    J Clin Pathol; 2006 Sep; 59(9):921-6. PubMed ID: 16565223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical examination of the INK4 and Cip inhibitors in the rat neonatal cerebellum: cellular localization and the impact of protein calorie malnutrition.
    Shambaugh GE; Haines GK; Koch A; Lee EJ; Zhou Jn; Pestell R
    Brain Res; 2000 Feb; 855(1):11-22. PubMed ID: 10650125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple degradation pathways regulate versatile CIP/KIP CDK inhibitors.
    Starostina NG; Kipreos ET
    Trends Cell Biol; 2012 Jan; 22(1):33-41. PubMed ID: 22154077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
    Reynisdóttir I; Polyak K; Iavarone A; Massagué J
    Genes Dev; 1995 Aug; 9(15):1831-45. PubMed ID: 7649471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
    Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
    Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation.
    Tanner FC; Boehm M; Akyürek LM; San H; Yang ZY; Tashiro J; Nabel GJ; Nabel EG
    Circulation; 2000 May; 101(17):2022-5. PubMed ID: 10790340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of mice without Cip/Kip CDK inhibitors.
    Tateishi Y; Matsumoto A; Kanie T; Hara E; Nakayama K; Nakayama KI
    Biochem Biophys Res Commun; 2012 Oct; 427(2):285-92. PubMed ID: 23000166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin dependent kinase inhibitors.
    Harper JW
    Cancer Surv; 1997; 29():91-107. PubMed ID: 9338098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-cycle inhibitors: three families united by a common cause.
    Vidal A; Koff A
    Gene; 2000 Apr; 247(1-2):1-15. PubMed ID: 10773440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic characterization of the role of the Cip/Kip family of proteins as cyclin-dependent kinase inhibitors and assembly factors.
    Cerqueira A; Martín A; Symonds CE; Odajima J; Dubus P; Barbacid M; Santamaría D
    Mol Cell Biol; 2014 Apr; 34(8):1452-9. PubMed ID: 24515438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin-dependent kinase inhibitors in malignant hematopoiesis.
    Schirripa A; Sexl V; Kollmann K
    Front Oncol; 2022; 12():916682. PubMed ID: 36033505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDK inhibitors: cell cycle regulators and beyond.
    Besson A; Dowdy SF; Roberts JM
    Dev Cell; 2008 Feb; 14(2):159-69. PubMed ID: 18267085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The multiple roles of the cyclin-dependent kinase inhibitory protein p57(KIP2) in cerebral cortical neurogenesis.
    Tury A; Mairet-Coello G; DiCicco-Bloom E
    Dev Neurobiol; 2012 Jun; 72(6):821-42. PubMed ID: 22076965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The activity and stability of the intrinsically disordered Cip/Kip protein family are regulated by non-receptor tyrosine kinases.
    Huang Y; Yoon MK; Otieno S; Lelli M; Kriwacki RW
    J Mol Biol; 2015 Jan; 427(2):371-386. PubMed ID: 25463440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. lin-35 Rb and cki-1 Cip/Kip cooperate in developmental regulation of G1 progression in C. elegans.
    Boxem M; van den Heuvel S
    Development; 2001 Nov; 128(21):4349-59. PubMed ID: 11684669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.